Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations: NEJ005/TCOG0902.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2012
Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002).
Annals of oncology : official journal of the European Society for Medical Oncology·2012
[The history of HIV].
Uirusu·2026